Implications for the future of obesity management

Peptides in Energy Balance and Obesity: Frontiers in Nutritional Science

Volumn , Issue , 2009, Pages 369-389

  Chaldakov, George N ^a   Tonchev, Anton B ^a   Fiore, Marco ^b   Hristova, Mariyana G ^a   Pancheva, Rouzha ^a   Rancic, Gorana ^c   Aloe, Luigi ^b  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b CNR   (Italy)

^c Department of Histology and Embryology ^*  (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954749744     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (125)

1. Ahmet, I., Wan, R., Mattson, M.P., Lakatta, E.G. and Talan, M. (2005) Cardioprotection by intermittent fasting in rats. Circulation 112, 3115-3121.
2. Allen, S.J. and Dawbarn, D. (2006) Clinical relevance of the neurotrophins and their receptors. Clinical Science (London) 11, 175-191.
3. Aloe, L. and Calza, L. (eds) (2004) NGF and Related Molecules in Health and Disease. Progress in Brain Research 146. Elsevier Science B.V., Amsterdam, pp. 3-527.
4. Alvarez-Llamas, G., Szalowska, E., Vries, M.P. de, Weening, D., Landman, K., Hoek, A., Wolffenbuttel, B.H., Roelofsen, H. and Vonk, R.J. (2007) Characterization of the human adipose tissue secretome. Molecular and Cellular Proteomics 6, 589-600.
5. Armeni, T., Pricipato, G., Quiles, J.L., Pieri, C., Bompadre, S. and Battino, M. (2003) Mitochondrial dysfunctions during aging: vitamin E deficiency or caloric restriction -two different ways of modulating stress. Journal of Bioenergy and Biomembranes 35, 181-191.
6. Baker, A.R., Silva, N.F., Quinn, D.W., Harte, A.L., Pagano, D., Bonser, R.S., Kumar, S. and McTernan, P.G. (2006) Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovascular Diabetology 5, 1.
7. Barnett, A. (2006) DPP-4 inhibitors and their potential role in the management of type 2 diabetes. International Journal of Clinical Practice 60, 1454-1470.
8. Beltowski, J. (2006) Apelin and visfatin: Unique 'beneficial' adipokines upregulated in obesity?. Medical Science Monitor 12, RA112-119.
9. Benga, G. (2006) Aquaporin7 and adipose tissue. Biomedical Reviews 17, 102-108.
10. Berg, A.H. and Scherer, P.E. (2005) Adipose tissue, inflammation, and cardiovascular diseases. Circulation Research 96, 939-949.
11. Bocsi, J., Mittag, A., Sack, U., Gerstner, A.O., Barten, M.J. and Tarnok, A. (2006) Novel aspects of systems biology and clinical cytomics. Cytometry 69, 105-108.
12. Boss, O. and Bergenhem, N. (2006) Adipose targets for obesity drug development. Expert Opinion and Therapeutic Targets 10, 119-134.
13. Botchkarev, V.A., Botchkareva, N.V., Peters, E.M.J. and Paus, R. (2004) Epithelial growth control by neurotrophins: leads and lessons from the hair follicle. Progress in Brain Research 146, 493-514.
14. Bray, G.A. and Bouchard, C. (eds) (2004) Handbook of Obesity, 2nd edition. Marcel Dekker Inc., New York.
15. Cai, D., Holm, J.M., Duignan, I.J., Zheng, J., Xaymardan, M., Chin, A., Ballard, V.L.T., Bella, J.N. and Edelberg, J.M. (2006) BDNF-mediated enhancement of inflammation and injury in the aging heart. Physiological Genomics 24, 191-197.
16. Cancello, R. and Clement, K. (2006) Is obesity an inflammatory illness? Role of low-grade inflammation associated with macrophage infiltration in human white adipose tissue. British Journal of Obstetrics and Gynaecology 113, 1141-1147.
17. Candore, G., Balisteri, C.R., Grimaldi, M.P., Listi, F., Vasto, S., Caruso, M., Caimi, G., Hoffmann, E., Colonna-Romano, G., Lio, D., Paolisso, G., Franceschi, C. and Caruso, C. (2006) Opposite role of pro-inflammatory alleles in acute myocardial infarction and longevity: results of studies performed in a Sicilian population. Annals of the New York Academy of Sciences 1067, 270-275.
18. Celis, J.E., Moreira, J.M., Cabezon, T., Gromov, P., Friis, E., Rank, F. and Gromova, I. (2005) Identification of extracellular and intracellular components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: towards dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Molecular and Cellular Proteomics 4, 492-522.
19. Chaldakov, G.N. and Vankov, V.N. (1986) Morphological aspects of the secretion in the arterial smooth muscle cell, with special reference to the Golgi complex and microtubular cytoskeleton. Atherosclerosis 61, 175-192.
20. Chaldakov, G.N., Fiore, M., Ghenev, P.I., Stankulov, I.S. and Aloe, L. (2000) Atherosclerotic lesions: possible interactive involvement of intima, adventition and associated adipose tissue. International Medical Journal 7, 43-49.
21. Chaldakov, G.N., Fiore, M., Stankulov, I.S., Hristova, M., Antonelli, A., Manni, L., Ghenev, P.I., Angelucci, F. and Aloe, L. (2001a) NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome. Archives of Physiology and Biochemistry 109, 357-360.
22. Chaldakov, G.N., Stankulov, I.S., Fiore, M., Hristova, M.G., Rancic, G., Ghenev, P.I. and Pavlov, P.S. (2001b) Adipoendocrinology and adipoparacrinology: emerging fields of study on the adipose tissue. Biomedical Reviews 12, 31-39.
23. Chaldakov, G.N., Fiore, M., Hristova, M. and Aloe, L. (2003a) Metabotrophic potential of neurotrophins: implication in obesity and related diseases. Medical Science Monitor 21, H19-21.
24. Chaldakov, G.N., Stankulov, I.S., Hristova, M. and Ghenev, P.I. (2003b) Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Current Pharmaceutical Design 9, 1023-1031.
25. Chaldakov, G.N., Fiore, M., Stankulov, I.S., Manni, L., Hristova, M.G., Antonelli, A., Ghenev, P.I. and Aloe, L. (2004) Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?. Progress of Brain Research 146, 279-289.
26. Chaldakov, G.N., Tonchev, A.B., Georgieva, Z., Ghenev, P.I. and Stankulov, I.S. (2005) Adipobiology of inflammation. Biomedical Reviews 16, 83-88.
27. Chaldakov, G.N., Fore, M., Tonchev, A.B. and Aloe, L. (2006a) Adipopharmacology, a novel drug discovery approach. A metabotrophic perspective. Letters of Drug Design and Discovery 3, 503-505.
28. Chaldakov, G.N., Tonchev, A.B., Tuncel, N., Atanassova, P. and Aloe, L. (2006b) Adipose tissue and mast cells. Adipokines as yin-yang modulators of inflammation. In: Fantuzzi, G. and Mazzone, T. (eds) Nutrition and Health: Adipose Tissue and Adipokines in Health and Disease. Humana Press Inc., Totowa, New Jersey, pp. 147-154.
29. Chaldakov, G.N., Fiore, M., Tonchev, A.B., Dimitrov, D., Pancheva, R., Rancic, G. and Aloe, L. (2007) Homo obesus: a metabotrophin-deficient species. Pharmacology and nutrition insight. Current Pharmaceutical Design 13, 2176-2179.
30. Chen, P.S., Chen, L.S., Cao, J.M., Sharifi, B., Karagueuzian, H.S. and Fishbein, M.C. (2001) Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovascular Research 50, 409-416.
31. Chen, D. and Guarente, L. (2007) SIR2: a potential target for calorie restriction mimetics. Trends in Molecular Medicine 13, 64-71.
32. Cheng, K.K.Y., Lam, K.S.L., Wang, Y. and Xu, A. (2006) Adiponectin as a key player in inflammation. Biomedical Reviews 17, 3-12.
33. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S. and Obin, M.S. (2005) Adipocyte death defines macrophage location and function in adipose tissue of obese mice and humans. Journal of Lipid Research 46, 2347-2355.
34. Del Porto, F., Aloe, L., Lagana, B., Triaca, V., Nofroni, I. and D'Amelio, R. (2006) NGF and BDNF levels in patients with rheumatoid arthritis treated with TNF-a blockers. Annals of the New York Academy of Sciences 1069, 438-443.
35. Dimitrov, D., Bohchelian, H. and Koeva, L. (2005) Effect of orlistat on plasma leptin levels and risk factors for the metabolic syndrome. Metabolic Syndrome and Related Disorders 3, 149-156.
36. Dimitrov, D., Pancheva, R., Tonchev, A.B., Kosseva, K., Kostov, D., Georgieva, Z. and Chaldakov, G.N. (2006) Nutrigenomics: DNA-based individualized nutrition. Biomedical Reviews 17, 109-114.
37. Ejiri, J., Inoue, N., Kobayashi, S., Shiraki, R., Otsui, K., Honjo, T., Takahashi, M., Ohashi, Y., Ichikawa, S., Terashima, M., Mori, T., Awano, K., Shinke, T., Shite, J., Hirata, K., Yokozaki, H., Kawashima, S. and Yokoyama, M. (2005) Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 112, 2114-2120.
38. Fain, J.N. (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the non-fat cells. Vitamins and Hormones 74, 443-477.
39. Fainzilber, M. and Carter, B.D. (2002) From neurotrophins to immunotrophins. EMBO Reports 3, 1029-1034.
40. Fantuzzi, G. (2005) Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology 115, 911-919.
41. Fantuzzi, G. (2007) Adipose tissue and the regulation of inflammation. Immunology Endocrine and Metabolic Agents in Medicinal Chemistry 7, 129-136.
42. Flachs, P., Mohamed-Ali, V., Horakova, D., Rossmeisl, M., Hosseinzadeh-Attar, M.J., Hensler, M., Ruzickova, J. and Kopecky, J. (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49, 394-397.
43. Foster-Schubert, K.E. and Cummings, D.E. (2006) Emerging therapeutic strategies for obesity. Endocrine Reviews 27, 779-793.
44. Franceschi, C., Valensin, S., Lescai, F., Olivieri, F., Licastro, F., Grimaldi, L.M., Monti, D., De Benedictis, G. and Bonafè, M. (2001) Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro-inflammatory phenotype. Aging (Milano) 13, 163-170.
45. Frühbeck, G. (2005) Aquaporin enters the picture. Nature 438, 436-437.
46. Frühbeck, G. (2006) Vasoactive factors and inflammatory mediators produced in adipose tissue. In: Fantuzzi, G. and Mazzone, T. (eds) Health and Nutrition. Adipose Tissue and Adipokines in Health and Disease. Humana Press, Inc., Totowa, New Jersey, pp. 61-75.
47. Frühbeck, G., Catalan, V., Gomez-Ambrosi, J. and Rodriguez, A. (2006) Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways. Trends of Pharmacological Sciences 27, 345-347.
48. Funahashi, T. and Matsuzawa, Y. (2006) Hypoadiponectinemia: a common basis for diseases associated with overnutrition. Current Atherosclerosis Reports 8, 433-438.
49. Funahashi, T., Nakamura, T., Shimomura, I., Maeda, K., Kuriyama, H., Takahashi, M., Arita, Y., Kihara, S. and Matsuzawa, Y. (1999) Role of adipocytokines on the pathogenesis of atherosclerosis in vascular obesity. Internal Medicine 38, 202-206.
50. Gallwitz, B. (2006) Therapies for the treatment of type 2 diabetes mellitus based on incretin action. Minerva Endocrinology 31, 133-147.
51. Geroldi, D., Minoretti, P. and Emanuele, E. (2006) Brain-derived neurotrophic factor and metabolic syndrome: more than just a hypothesis. Medical Hypotheses 67, 195-196.
52. Ghosh, D., Skinner, M.A. and Laing, W.A. (2007) Pharmacogenomics and nutrigenomics: synergies and differences. European Journal of Clinical Nutrition 61, 567-574.
53. Gianoukakis, A.G. and Smith, T.J. (2008) Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Current Opinion in Endocrinology, Diabetes, and Obesity 15, 446-452.
54. Goldstein, B.J. and Scalia, R. (2007) Adipocytokines and vascular disease in diabetes. Current Diabetes Reports 7, 25-32.
55. Gray, J., Yeo, G., Hung, C., Keogh, J., Clayton, P., Banerjee, K., McAulay, A., O'Rahilly, S. and Farooqi, S. (2007) Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. International Journal of Obesity 31, 359-364.
56. Grimaldi, M.P., Candore, G., Vasto, S., Caruso, M., Gaimi, G., Hoffmann, E., Colonna-Romano, G., Lio, D., Shinar, Y., Franceschi, C. and Caruso, C. (2006) Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population. Journal of Leukocyte Biology 79, 611-615.
57. Guarente, L. and Picard, F. (2005) Calorie restriction -the SIR2 connection. Cell 120, 473-482.
58. Halberg, N., Henrikson, M., Soderhamn, N., Stallkecht, B., Plough, T., Schjerling, P. and Dela, F. (2005) The effect of intermittent fasting and re-feeding on insulin action in healthy men. Journal of Applied Physiology 99, 2128-2136.
59. Hefti, F.F., Rosenthal, A., Walicke, P.A., Wyatt, S., Vergata, G., Shelton, D.L. and Davies, A.M. (2006) Novel class of pain drugs based on antagonism of nerve growth factor. Trends in Pharmacological Sciences 27, 85-91.
60. Himeda, T., Tounai, H., Hayakawa, N. and Araki, T. (2007) Post-ischemic alterations of BDNF, NGF, HSP 70 and ubiquitin immunoreactivity in the gerbil hypothalamus: pharmacological approach. Cellular and Molecular Neurobiology 27, 229-250.
61. Hofbauer, K.G, Nicholson, J.K. and Boss, O. (2007) The obesity epidemics: current and future pharmacological treatments. Annual Review of Pharmacology and Toxicology 47, 565-592.
62. Hristova, M., Aloe, L., Ghenev, P.I., Fiore, M. and Chaldakov, G.N. (2001) Leptin and mast cells: a novel adipoimmune link. Turkish Journal of Medical Sciences 31, 581-583.
63. Iacobellis, G., Corradi, D. and Sharma, A.M. (2005) Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nature Clinical Practice and Cardiovascular Medicine 2, 536-543.
64. Kadowaki, T. and Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocrine Reviews 26, 439-451.
65. Kalra, S.P. and Kalra, P.S. (2005) Gene-transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life expectancy. Trends in Pharmacological Sciences 26, 488-495.
66. Keusch, G.T. (2006) What do -omics mean for the science and policy of the nutritional sciences?. American Journal of Clinical Nutrition 83, 520S-522S.
67. Kim, Y.J., Kim, H.J., No, J.K., Chung, H.Y., Fernandes, G. (2006) Anti-inflammatory action of dietary fish oil and calorie restriction. Life Sciences 78, 2523-2532.
68. Kim, M.J., Lee, E.Y., Lee, M.Y. and Chung, C.H. (2007) Adipobiology of diabetes mellitus. Immunology Endocrine and Metabolic Agents in Medicinal Chemistry 7, 123-127.
69. Klein, J., Permana, P.A., Owecki, M., Chaldakov, G.N., Böhm, M., Hausman, G., Lapière, C.M., Atanassova, P., Sowinski, J., Fasshauer, M., Hausman, D.B., Maquoi, E., Tonchev, A.B., Peneva, V.N., Vlachanov, K.P., Fiore, M., Aloe, L., Slominski, A., Reardon, C.L., Ryan, T.J., Pond, C.M. and Ryan, T.J. (2007) What are subcutaneous adipocytes really good for?. Experimental Dermatology 16, 45-70.
70. Kokai, L.E., Rubin, J.P. and Marra, K.G. (2005) The potential of adipose-derived adults stem cells as a source of neuronal progenitor cells. Plastic and Reconstructive Surgery 116, 1453-1460.
71. Krabbe, K.S., Nielsen, A.R., Krogh-Madsen, R., Plomgaard, P., Rasmussen, P., Erikstrup, C., Fischer, C.P., Lindegaard, B., Peteresen, A.M.W., Taudorf, S., Secher, N.H., Pilegaard, H., Bruunsgaard, H. and Pedersen, B.K. (2006) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia. 50, 431-438.
72. Kralisch, S., Blüher, M., Paschke, R., Stumvoll, M. and Fasshauer, M. (2007) Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome. Mini Reviews Medicinal Chemistry 7, 39-45.
73. Kratchmarova, I., Kalume, D.E., Blagoev, B., Scherer, P.E., Podtelejnikov, A.V., Molina, H., Bickel, P.E., Andersen, J.S., Ferandez, M.M., Bunkenborg, J., Roepstorff, P., Kristiansen, K., Lodish, H.F., Mann, M. and Pandey, A. (2002) A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Molecular and Cellular Proteomics 1, 213-222.
74. Lamming, D.W., Wood, J.G. and Sinclair, D.A. (2004) Small molecules that regulate lifespan: evidence for xenohormesis. Molecular Microbiology 53, 1003-1009.
75. Lopez-Lluch, G., Hunt, N., Jones, B., Zhu, M., Jamieson, H., Hilmer, S., Cascajo, M.V., Allard, J., Ingram, D.K., Navas, P. and Cabo, R. de (2006) Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proceedings of National Academy of Sciences of the United States of America 103, 1768-1773.
76. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 8, 731-737.
77. Manni, L., Nikolova, V., Vyagova, D., Chaldakov, G.N. and Aloe, L. (2005) Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. International Journal of Cardiology 102, 169-171.
78. Matsuzawa, Y. (2006) Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nature Clinical Practice and Cardiovascular Medicine 3, 35-42.
79. Mizuno, T., Kurotani, T., Komatsu, Y., Kawanokuchi, J., Kato, H., Mitsuma, N. and Suzumura, A. (2004) Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 46, 404-411.
80. Moschen, A.R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niebergger, H. and Tilg, H. (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulatory properties. Journal of Immunology 178, 1748-1758.
81. Nakagawa, T., Ogawa, Y., Ebihara, K., Yamanaka, M., Tsuchida, A., Taiji, M., Noguchi, H. and Nakao, K. (2003) Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance. International Journal of Obesity and Related Metabolic Disorders 27, 557-565.
82. Narasimhan, I.M., Coca, M.A., Jin, J., Yamauchi, T., Ito, Y., Kadowaki, T., Kim, K.K., Pardo, J.M., Damsz, B., Hasegawa, P.M., Yun, D.J. and Bressan, R.A. (2005) Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor. Molecular Cell 17, 171-180.
83. Neel, J.V. (1962) Diabetes mellitus: a 'thrifty' genotype rendered detrimental by 'progress'?. American Journal of Human Genetics 14, 353-362.
84. Neels, J.G. and Olefsky, J.M. (2006) Inflamed fat: what starts the fair?. Journal of Clinical Investigation 116, 33-35.
85. Nishimura, F., Iwamoto, Y., Mineshiba, J., Shimizu, A., Soga, Y. and Murayama, Y. (2003) Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. Journal of Periodontology 74, 97-102.
86. Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., Moncada, S. and Carruba, M.O. (2005) Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310, 314-317.
87. Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y. and Libby, P. (2006) Adiponectin: a key adipocytokine in metabolic syndrome. Clinical Science (London) 110, 267-278.
88. Permana, P.A. (2006) Adipokine expression and secretion: a target for pharmacologic treatment. Biomedical Reviews 17, 72-81.
89. Petersen, A.M. and Pedersen, B.K. (2005) The anti-inflammatory effect of exercise. Journal of Applied Physiology 98, 1154-1162.
90. Pond, C. (2003) Paracrine relationships between adipose and lymphoid tissue: implications for the mechanisms of HIV-associated adipose redistribution syndrome. Trends of Immunology 24, 13-18.
91. Pond, C.M. (2005) Adipose tissue and the immune system. Prostaglandins Leukocytes and Essential Fatty Acids 73, 17-30.
92. Pradova, E. and Fickova, M. (2006) Alcohol intake modulates hormonal activity of adipose tissue. Endocrine Regulation 40, 91-104.
93. Quinn, L.S., Strait-Bodey, L., Anderson, B.G., Argiles, J.M. and Havel, P.J. (2005) Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biology International 29, 449-457.
94. Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B., Kuehn, R., Lechan, R.M. and Jaenisch, R. (2001) Conditional deletion of brain-derived neurotrophic factor in post-natal brain leads to obesity and hyperactivity. Molecular Endocrinology 15, 1748-1757.
95. Rodriguez, A., Catalan, V., Gomez-Ambrosi, J. and Frühbeck, G. (2006) Role of AQP7 in the pathophysiological control of fat accumulation in mice. FEBS Letters 580, 4771-4776.
96. Ross, R. (1999) Mechanisms of disease: atherosclerosis -an inflammatory disease. New England Journal of Medicine 340, 115-126.
97. Roth, G.S., Lane, M.A. and Ingram, D.K. (2005) Caloric restriction mimetics: the next phase. Annals of the New York Academy of Sciences 57, 365-371.
98. Schaffler, A., Scholmerich, J. and Buchler, C. (2005) Mechanisms of disease: adipocytokines and visceral adipose tissue -emerging role in non-alcoholic liver disease. Nature Clinical Practice Gastroenterology and Hepatology 2, 273-280.
99. Scott, E.M. and Grant, P.J. (2006) Neel revisited: the adipocyte, seasonality and type 2 diabetes. Diabetologia 49, 1462-1466.
100. Seki, M., Tanaka, T., Nawa, H., Usui, T., Fukuchi, T., Ikeda, K., Abe, H. and Takei, N. (2004) Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53, 2412-2419.
101. Shimomura, I., Funahashi, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., Tokunaga, K. and Matsuzawa, Y. (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Medicine 2, 800-803.
102. Shimomura, I., Hammer, R.E., Richardson, J.A., Ikemo, S., Bashmakov, Y., Goldstein, J.L. and Brown, M.S. (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes and Development 12, 3182-3194.
103. Shimomura, I., Funahashi, T. and Matsuzawa, Y. (2006) Metabolic syndrome, adiponectin and fat ROS. Biomedical Reviews 17, 1-10.
104. Sjogren, M. and Blennow, K. (2005) The link between cholesterol and Alzheimer's disease. World Journal of Biological Psychiatry 6, 85-97.
105. Sun, M.K. and Alkon, D.L. (2006) Links between Alzheimer's disease and diabetes. Drugs Today (Barc) 42, 481-489.
106. Suwa, M., Kishimoto, H., Nofuji, Y., Nakano, H., Sasaki, H., Radak, Z. and Kumagai, S. (2006) Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism Clinical and Experimental 55, 852-857.
107. Tilg, H. and Moschen, A.R. (2008) Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clinical Science (London) 114, 275-288.
108. Töre, F., Tonchev, A.B, Fiore, M., Atanassova, P., Tuncel, N., Aloe, L. and Chaldakov, G.N. (2007) From adipose tissue protein secretion to adipopharmacology of disease. Immunology Endocrine and Metabolic Agents in Medicinal Chemistry 7, 149-155.
109. Trapp, J. and Jung, M. (2006) The role of NAD+ dependent histone deacetylases (sirtuins) in ageing. Current Drug and Targets 7, 1553-1560.
110. Trayhurn, P. and Wood, I.S. (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 92, 347-355.
111. Tsuji-Hayashi, Y., Young, B.A., Green, J., Tsuji, A., Hosoya, T., Fukuhara, S. and Blagg, C.R. (2005) Health-related quality of life among community-dwelling elderly people in the general populations of the US and Japan. Japan Medical Association Journal 48, 489-496.
112. Viguerie, N., Pottou, C., Cancello, R., Stich, V., Clement, K. and Langin, D. (2005) Transcriptomics applied to obesity and caloric restriction. Biochemie 87, 117-123.
113. Waki, H. and Tontonoz, P. (2007) Endocrine function of adipose tissue. Annual Review of Pathology: Mechanisms of Disease 2, 31-56.
114. Wang, P., Mariman, E., Renes, J. and Keijer, J. (2008) The secretary function of adipocytes in the physiology of white adipose tissue. Journal of Cellular Physiology 216, 3-13.
115. Wintour, E.M. and Henry, B.A. (2006) Glycerol transport: an additional target for obesity therapy?. Trends of Endocrinology and Metabolism 17, 77-78.
116. Xavier Pi-Sunyer, F. (2006) The relation of adipose tissue to cardiometabolic risk. Clinical Cornerstone 8 (Suppl. 4), S14-23.
117. Xu, A., Chan, K.W., Hoo, R.L.C., Wang, Y., Tan, K.C.B., Zhang, J., Chen, B., Lam, M.C., Tse, C., Cooper, G.J.S. and Lam, K.S.L. (2005a) Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. Journal of Biological Chemistry 280, 18073-18080.
118. Xu, A., Laam, M.C., Chan, K.W., Wang, Y., Zhang, J., Hoo, R.L.C., et al. (2005b) Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proceedings of National Academy of Sciences of the United States of America 102, 6086-6092.
119. Yamori, Y. (2004) Worldwide epidemic of obesity: hope for Japanese diets. Clinical Experimental Pharmacology and Physiology 31 (Suppl. 2), S2-4.
120. Yamori, Y., Murakami, S., Ikeda, K. and Nara, Y. (2004) Fish and lifestyle-related disease prevention: experimental and epidemiological evidence for anti-atherogenic potential of taurine. Clinical Experimental Pharmacology and Physiology 31 (Suppl. 2), S20-23.
121. Yeo, G.S. Connie Hung, C.C., Rochford, J., Keogh, J., Gray, J., Sivaramakrishnan, S., O'Rahilly, S. and Farooqi, I.S. (2004) A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature Neuroscience 7, 1187-1189.
122. Yudkin, J.S., Eringa, E. and Stehouwer, C.D.A. (2005) 'Vasocrine' signalling from perivascular fat: a mechansim linking insulin resistance to vascular diseases. Lancet 365, 1817-1820.
123. Yun, A.J., Lee, P.Y. and Doux, J.D. (2006) Are we eating more than we think? Illegitimate signaling and xenohormesis as participants in the pathogenesis of obesity. Medical Hypotheses 67, 36-40.
124. Zigman, J.M. and Elmquist, J.K. (2003) Minireview: from anorexia to obesity -the yin and yang of body weight control. Endocrinology 144, 3749-3756.
125. Zvonic, S., Lefevre, M., Kilroy, G., Floyd, Z.E., Delany, J.P., Kheterpal, I., Gravos, A., Dow, R., White, A., Wu, X. and Gimble, J.M. (2007) Secretome of primary culture of human adipose stem cells: modulation of serpins by adipogenesis. Molecular and Cellular Proteomics 6, 18-28.